![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/a/ae/Parsaclisib.svg/640px-Parsaclisib.svg.png&w=640&q=50)
Parsaclisib
Investigational medication / From Wikipedia, the free encyclopedia
Parsaclisib is an investigational drug that it being evaluated for the treatment of B-cell malignancies. It is a PI3Kδ (phosphoinositide 3-kinase) inhibitor.[1][2]
Quick Facts Clinical data, ATC code ...
![]() | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C20H22ClFN6O2 |
Molar mass | 432.88 g·mol−1 |
3D model (JSmol) | |
| |
|
Close